Trichloroacetic acid 10% injection for treatment of conjunctival inclusion cysts. (3rd March 2020)

• Record Type: Journal Article
• Authors: Bagheri, Abbas; Shahraki, Koroush; Yazdani, Shahin
• Is Part Of: Orbit. Volume 39:Number 2(2020)
• Page Start: 107
• Page End: 111
• Publication Date: 2020-03-03
• Subjects: Anophthalmic socket -- conjunctival cyst -- ophthalmic socket -- trichloroacetic acid; Eye-sockets -- Surgery -- Periodicals; Eye-sockets -- Diseases -- Periodicals; Orbit -- surgery -- Periodicals; Orbital Diseases -- Periodicals; 617.7
• DOI: 10.1080/01676830.2019.1631358
• Languages: English
• ISSNs: 0167-6830

Abstract

ABSTRACT: Purpose : To evaluate the effect of intra-lesional injection of Trichloroacetic acid (TCA) 10% in patients with conjunctival inclusion cysts. Methods : This prospective case series study included all patients with conjunctival inclusion cyst who were referred to our referral center from August 2016 to August 2018. All patients received TCA 10% injection into the conjunctival cyst, and outcomes of the intervention were evaluated at least 6 months later. Results : Ten patients with mean age of 24 ± 17.6 (range 6–65) years including three children received TCA 10% injection into the conjunctival cyst. We included 6 anophthalmic and 4 ophthalmic cases. All patients were treated successfully and no recurrence of the lesion was observed in any case. Mean follow up duration was 18.1 ± 8.3 (range 6–28) months. Conclusion : Intra-lesional injection of TCA 10% is a safe, simple, and effective treatment in patients with conjunctival inclusion cysts including ophthalmic cases and anophthalmic cases, both in adults and in children. This concentration may avoid ocular surface complications.